全文获取类型
收费全文 | 8957篇 |
免费 | 554篇 |
国内免费 | 72篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 261篇 |
妇产科学 | 216篇 |
基础医学 | 1355篇 |
口腔科学 | 141篇 |
临床医学 | 669篇 |
内科学 | 2313篇 |
皮肤病学 | 283篇 |
神经病学 | 782篇 |
特种医学 | 325篇 |
外科学 | 935篇 |
综合类 | 17篇 |
预防医学 | 550篇 |
眼科学 | 91篇 |
药学 | 688篇 |
中国医学 | 16篇 |
肿瘤学 | 883篇 |
出版年
2024年 | 9篇 |
2023年 | 75篇 |
2022年 | 172篇 |
2021年 | 295篇 |
2020年 | 166篇 |
2019年 | 238篇 |
2018年 | 249篇 |
2017年 | 193篇 |
2016年 | 249篇 |
2015年 | 285篇 |
2014年 | 344篇 |
2013年 | 447篇 |
2012年 | 713篇 |
2011年 | 734篇 |
2010年 | 374篇 |
2009年 | 353篇 |
2008年 | 584篇 |
2007年 | 564篇 |
2006年 | 571篇 |
2005年 | 584篇 |
2004年 | 510篇 |
2003年 | 462篇 |
2002年 | 386篇 |
2001年 | 93篇 |
2000年 | 86篇 |
1999年 | 101篇 |
1998年 | 88篇 |
1997年 | 67篇 |
1996年 | 61篇 |
1995年 | 48篇 |
1994年 | 39篇 |
1993年 | 37篇 |
1992年 | 49篇 |
1991年 | 45篇 |
1990年 | 38篇 |
1989年 | 31篇 |
1988年 | 26篇 |
1987年 | 22篇 |
1986年 | 29篇 |
1985年 | 21篇 |
1984年 | 15篇 |
1983年 | 13篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 13篇 |
1978年 | 9篇 |
1977年 | 10篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1966年 | 8篇 |
排序方式: 共有9583条查询结果,搜索用时 15 毫秒
991.
992.
Giorgio Grani Mimma D’Alessandri Giovanni Carbotta Angela Nesca Marianna Del Sordo Stefania Alessandrini Carmela Coccaro Roberta Rendina Marta Bianchini Natalie Prinzi Angela Fumarola 《Medicine》2015,94(27)
Ultrasonography is the main imaging method for the workup of thyroid nodules. However, interobserver agreement reported for echogenicity and echotexture is quite low. The aim of this study was to perform quantitative measurements of the degree of echogenicity and heterogeneity of thyroid nodules, to develop an objective and reproducible method to stratify these features to predict malignancy.A retrospective study of patients undergoing ultrasonography-guided fine-needle aspiration was performed in an University hospital thyroid center. From January 2010 to October 2012, 839 consecutive patients (908 nodules) underwent US-guided fine-needle aspiration. In a single ultrasound image, 3 regions of interest (ROIs) were drawn: the first including the nodule; the second including a portion of the adjacent thyroid parenchyma; the third, the strap muscle. Histogram analysis was performed, expressing the median, mean, and SD of the gray levels of the pixels comprising each region. Echogenicity was expressed as a ratio: the nodule/parenchyma, the nodule/muscle, and parenchyma/muscle median gray ratios were calculated. The heterogeneity index (HI) was calculated as the coefficient of variation of gray histogram for each of the 3 ROIs. Cytology and histology reports were recorded.Nodule/parenchyma median gray ratio was significantly lower (more hypoechoic) in nodules found to be malignant (0.45 vs 0.61; P = 0.002) and can be used as a continuous measure of hypoechogenicity (odds ratio [OR] 0.12; 95% confidence interval [CI] 0.03–0.49). Using a cutoff derived from ROC curve analysis (<0.46), it showed a substantial inter-rater agreement (k = 0.74), sensitivity of 56.7% (95% CI 37.4–74.5%), specificity of 72.0% (67.8–75.9%), positive likelihood ratio (LR) of 2.023 (1.434–2.852), and negative LR of 0.602 (0.398–0.910) in predicting malignancy (diagnostic odds ratio 3.36; 1.59–7.10). Parenchymal HI was associated with anti-thyroperoxidase positivity (OR 19.69; 3.69–105.23). The nodule HI was significantly higher in malignant nodules (0.73 vs 0.63; P = 0.03) and, if above the 0.60 cutoff, showed sensitivity of 76.7% (57.7–90.1%), specificity of 46.8% (42.3–51.4%), positive LR of 1.442 (1.164–1.786), and negative LR of 0.498 (0.259–0.960).Evaluation of nodule echogenicity and echotexture according to a numerical estimate (nodule/parenchyma median gray ratio and nodule HI) allows for an objective stratification of nodule echogenicity and internal structure. 相似文献
993.
Andrew J Boyle Stefania Di Gangi Umar I Hamid Linda-Jayne Mottram Lia McNamee Griania White LJ Mark Cross James J McNamee Cecilia M O’Kane Daniel F McAuley 《Critical care (London, England)》2015,19(1)
IntroductionAcute respiratory distress syndrome (ARDS) is a common clinical syndrome with high mortality and long-term morbidity. To date there is no effective pharmacological therapy. Aspirin therapy has recently been shown to reduce the risk of developing ARDS, but the effect of aspirin on established ARDS is unknown.MethodsIn a single large regional medical and surgical ICU between December 2010 and July 2012, all patients with ARDS were prospectively identified and demographic, clinical, and laboratory variables were recorded retrospectively. Aspirin usage, both pre-hospital and during intensive care unit (ICU) stay, was included. The primary outcome was ICU mortality. We used univariate and multivariate logistic regression analyses to assess the impact of these variables on ICU mortality.ResultsIn total, 202 patients with ARDS were included; 56 (28%) of these received aspirin either pre-hospital, in the ICU, or both. Using multivariate logistic regression analysis, aspirin therapy, given either before or during hospital stay, was associated with a reduction in ICU mortality (odds ratio (OR) 0.38 (0.15 to 0.96) P = 0.04). Additional factors that predicted ICU mortality for patients with ARDS were vasopressor use (OR 2.09 (1.05 to 4.18) P = 0.04) and APACHE II score (OR 1.07 (1.02 to 1.13) P = 0.01). There was no effect upon ICU length of stay or hospital mortality.ConclusionAspirin therapy was associated with a reduced risk of ICU mortality. These data are the first to demonstrate a potential protective role for aspirin in patients with ARDS. Clinical trials to evaluate the role of aspirin as a pharmacological intervention for ARDS are needed. 相似文献
994.
995.
996.
Grazia Arpino Carmine De Angelis Giuseppe Buono Annamaria Colao Mario Giuliano Simona Malgieri Stefania Cicala Michelino De Laurentiis Antonello Accurso Anna Crispo Gennaro Limite Rossella Lauria Bianca Maria Veneziani Valeria Forestieri Dario Bruzzese Sabino De Placido 《Breast cancer research and treatment》2015,154(1):127-132
997.
Maria Lucibello Sara Adanti Ester Antelmi Dario Dezi Stefania Ciafrè Maria Luisa Carcangiu Manuela Zonfrillo Giuseppe Nicotera Lorenzo Sica Filippo De Braud Pasquale Pierimarchi 《Oncotarget》2015,6(7):5275-5291
Upregulation of Translationally Controlled Tumor Protein (TCTP) is associated with poorly differentiated aggressive tumors, including breast cancer, but the underlying mechanism(s) are still debated. Here, we show that in breast cancer cell lines TCTP is primarily localized in the nucleus, mostly in the phosphorylated form.The effects of Dihydroartemisinin (DHA), an anti-malaria agent that binds TCTP, were tested on breast cancer cells. DHA decreases cell proliferation and induces apoptotic cell death by targeting the phosphorylated form of TCTP. Remarkably, DHA enhances the anti-tumor effects of Doxorubicin in triple negative breast cancer cells resulting in an increased level of apoptosis. DHA also synergizes with Trastuzumab, used to treat HER2/neu positive breast cancers, to induce apoptosis of tumor cells.Finally, we present new clinical data that nuclear phospho-TCTP overexpression in primary breast cancer tissue is associated with high histological grade, increase expression of Ki-67 and with ER-negative breast cancer subtypes. Notably, phospho-TCTP expression levels increase in trastuzumab-resistant breast tumors, suggesting a possible role of phospho-TCTP as a new prognostic marker.In conclusion, the anti-tumor effect of DHA in vitro with conventional chemotherapeutics suggests a novel therapeutic strategy and identifies phospho-TCTP as a new promising target for advanced breast cancer. 相似文献
998.
Maura Calvani Floriane Pelon Giuseppina Comito Maria Letizia Taddei Silvia Moretti Stefania Innocenti Romina Nassini Gianni Gerlini Lorenzo Borgognoni Franco Bambi Elisa Giannoni Luca Filippi Paola Chiarugi 《Oncotarget》2015,6(7):4615-4632
Stress has an emerging role in cancer and targeting stress-related β-adrenergic receptors (AR) has been proposed as a potential therapeutic approach in melanoma. Here we report that β3-AR expression correlates with melanoma aggressiveness. In addition, we highlight that β3-AR expression is not only restricted to cancer cells, but it is also expressed in vivo in stromal, inflammatory and vascular cells of the melanoma microenvironment. Particularly, we demonstrated that β3-AR can (i) instruct melanoma cells to respond to environmental stimuli, (ii) enhance melanoma cells response to stromal fibroblasts and macrophages, (iii) increase melanoma cell motility and (iv) induce stem-like traits. Noteworthy, β3-AR activation in melanoma accessory cells drives stromal reactivity by inducing pro-inflammatory cytokines secretion and de novo angiogenesis, sustaining tumor growth and melanoma aggressiveness. β3-ARs also play a mandatory role in the recruitment to tumor sites of circulating stromal cells precursors, in the differentiation of these cells towards different lineages, further favoring tumor inflammation, angiogenesis and ultimately melanoma malignancy. Our findings validate selective β3-AR antagonists as potential promising anti-metastatic agents. These could be used to complement current therapeutic approaches for melanoma patients (e.g. propranolol) by targeting non-neoplastic stromal cells, hence reducing therapy resistance of melanoma. 相似文献
999.
Michele Dal Bo Tiziana D'Agaro Stefania Gobessi Antonella Zucchetto Sara Dereani Davide Rossi Francesco Zaja Gabriele Pozzato Francesco Di Raimondo Gianluca Gaidano Luca Laurenti Giovanni Del Poeta Dimitar G. Efremov Valter Gattei Riccardo Bomben 《Oncotarget》2015,6(22):19102-19117
The B-cell receptor (BCR) plays an important role in the pathogenesis and progression of chronic lymphocytic leukemia (CLL). By global microRNA profiling of CLL cells stimulated or not stimulated by anti-IgM, significant up-regulation of microRNAs from the miR-132~212 cluster was observed both in IGHV gene unmutated (UM) and mutated (M) CLL cells. Parallel gene expression profiling identified SIRT1, a deacetylase targeting several proteins including TP53, among the top-ranked miR-132 target genes down-regulated upon anti-IgM exposure. The direct regulation of SIRT1 expression by miR-132 was demonstrated using luciferase assays. The reduction of SIRT1 mRNA and protein (P = 0.001) upon anti-IgM stimulation was associated with an increase in TP53 acetylation (P = 0.007), and the parallel up-regulation of the TP53 target gene CDKN1A. Consistently, miR-132 transfections of CLL-like cells resulted in down-regulation of SIRT1 and an induction of a TP53-dependent apoptosis. Finally, in a series of 134 CLL samples, miR-132, when expressed above the median value, associated with prolonged time-to-first-treatment in patients with M CLL (HR = 0.41; P = 0.02). Collectively, the miR-132/SIRT1/TP53 axis was identified as a novel pathway triggered by BCR engagement that further increases the complexity of the interactions between tumor microenvironments and CLL cells. 相似文献